Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 5.0T | 4.7T | 4.2T | 3.9T |
Cost of revenue | 4.0T | 3.7T | 3.4T | 3.2T |
Gross profit | 1.0T | 930.1B | 765.0B | 655.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 716.9B | 695.3B | 623.6B | 556.7B |
Other operating expenses | 27.1B | 18.0B | 65.3B | 24.8B |
Operating income | 386.0B | 280.4B | 179.8B | 143.4B |
Non operating interest income | ||||
Income | 13.6B | 49.9B | 29.0B | 31.9B |
Expense | 22.3B | 17.3B | 31.2B | 18.5B |
Other income expense | — | — | — | — |
Pretax income | 374.5B | 315.2B | 191.1B | 173.7B |
Tax provision | 112.5B | 71.6B | 44.8B | 48.0B |
Net income | 262.0B | 243.6B | 146.3B | 125.7B |
Basic EPS | — | 66.1 | 38.8 | 33.8 |
Diluted EPS | — | 66.0 | 38.8 | 33.8 |
Basic average shares | — | 3.4B | 3.4B | 3.4B |
Diluted average shares | — | 3.4B | 3.4B | 3.4B |
EBITDA | 557.5B | 488.4B | 370.9B | 327.9B |
Net income from continuing op. | 374.5B | 315.2B | 191.1B | 173.7B |
Minority interests | -16.5B | -21.5B | -15.9B | -12.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |